Business
BioLife Solutions evo® Cold Chain Management Platform Now Supporting Over 100 Early Stage Cell & Gene Therapy Clinical Trials
Partnerships with Leading Specialty Couriers Driving Adoption BOTHELL, Wash., July 15, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife"
About this update from Biolife Solutions, Inc.
[{"type":"text","content":"Partnerships with Leading Specialty Couriers Driving Adoption\n\n\nBOTHELL, Wash., July 15, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) (\"BioLife\" or the \"Company\"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today provided an update on adoption of its evo cold chain management platform solution by cell and gene therapy companies.\n\n \n \n \n \n \n \n\n \nVia its relationships with leading specialty couriers World Courier and Quick International Courier, the evo platform is used to transport and monitor shipments of source material and manufactured doses in more than 100 cell and gene therapy clinical trials.\nMike Rice, BioLife's CEO, remarked, \"We highly value our relationships with World Courier and Quick International. Their combined worldwide footprint enables our evo platform to support clinical trials of novel cell and gene therapies in all major markets. In the second quarter of 2020, we gained 6 new cell and gene therapy customers that now use our smart, cloud-connected shipping containers and evo.is cloud app to manage shipments of high-value, time and temperature sensitive biologic materials.\"\nAlex Guite, Vice President of Services and Alliances at World Courier and ICS, two AmerisourceBergen companies, commented, \"The evo platform with the DV10 smart shipper enhances our offering to cell and gene therapy companies requiring cryogenic shipping for biological material. BioLife's commitment to innovation, quality and customer service make them an integral part of World Courier's logistics platform.\" \nJames Smith, Vice President of Global Operations at Quick remarked, \"We continue to offer liquid nitrogen shippers to the high growth cell and gene therapy market. The founders of SAVSU brought class-defining cold chain management solutions to this space with BioLife's insistence on quality by design and best practices. As a trusted leader in personalized medicine logistics and transportation, we see tremendous opportunities for both companies to serve mutual customers and raise the bar even higher.\"\nAbout World Courier\nWorld Courier provides unparalleled specialty logistics services to drive the commercial success of our partners around the globe. For 50 years, we've delivered peace of mind through world-class supply chai...